Form 4: Dynavax Technologies CFO Kelly MacDonald Reports Stock Transactions
SEC Form 4 Filing
Kelly MacDonald, SVP and CFO of Dynavax Technologies, reports the vesting of restricted stock units and subsequent stock transactions.
Summary
- On February 18, 2025, Kelly MacDonald, SVP and CFO of Dynavax Technologies, reported transactions involving Dynavax common stock.
- MacDonald acquired 15,477 shares of common stock through the vesting of restricted stock units (RSUs).
- Simultaneously, 4,975 shares were withheld by Dynavax to satisfy tax withholding requirements at a price of $12.93 per share.
- Following these transactions, MacDonald directly owns 29,227 shares of Dynavax common stock and 30,953 restricted stock units.
- The RSUs vest over three years, with 1/3 vesting annually on each anniversary of February 15, 2024.
Sentiment
Score: 5
Explanation: This is a routine filing related to executive compensation. It doesn't inherently indicate positive or negative sentiment, but rather reflects standard corporate practices.
Positives
- The vesting of RSUs indicates a form of compensation and alignment of the CFO's interests with the company's performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Comparison to Industry Standards
- Stock-based compensation, including RSUs, is a common practice among publicly traded companies, particularly in the biotechnology sector, to attract and retain key executives.
- Companies like Moderna (MRNA) and BioNTech (BNTX) also utilize stock options and RSUs as part of their executive compensation packages.
- The vesting schedules and terms of these equity grants are typically benchmarked against industry standards to ensure competitiveness.
Stakeholder Impact
- The transactions have a minor impact on shareholders, as they involve the issuance of new shares through RSU vesting, which can slightly dilute existing ownership.
Key Dates
| Date | Description |
|---|---|
| February 15, 2024 | Initial vesting date for 1/3 of the restricted stock units. |
| February 18, 2025 | Date of the reported stock transactions (vesting of RSUs and tax withholding). |
| February 20, 2025 | Date of signature on the Form 4 filing. |
Keywords
Dynavax Technologies, DVAX, Kelly MacDonald, CFO, stock, restricted stock units, RSU, Form 4, beneficial ownership, securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.